Jane Street’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-28,600
Closed -$469K 11136
2021
Q4
$469K Buy
+28,600
New +$596K ﹤0.01% 7390
2021
Q3
Sell
-42,800
Closed -$1.49M 10881
2021
Q2
$1.49M Sell
42,800
-31,200
-42% -$990K ﹤0.01% 4963
2021
Q1
$2.34M Buy
74,000
+23,500
+47% +$955K ﹤0.01% 3720
2020
Q4
$2.39M Sell
50,500
-3,600
-7% -$167K ﹤0.01% 3192
2020
Q3
$2.52M Buy
54,100
+8,400
+18% +$288K ﹤0.01% 2685
2020
Q2
$1.65M Buy
+45,700
New +$1.68M ﹤0.01% 3329

Other funds holding ZYME

Jane Street's ZYME Position: Q2 2026 in Review

Jane Street reduced its Zymeworks (ZYME) stake by 92% in Q2 2026, selling an estimated $5.32M and leaving 17,437 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #8244.

Jane Street first reported a position in ZYME in Q4 2018 and has held it in 23 quarters since. The position peaked at $5.68M in Q1 2026. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Jane Street held 17,437 shares of Zymeworks worth $456K as of Q2 2026.
  • Jane Street sold 209,530 Zymeworks shares in Q2 2026, an estimated $5.32M.
  • Zymeworks made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8244 holding.
  • Jane Street first reported a position in Zymeworks in Q4 2018 and has held it in 23 quarters since.
  • Jane Street's Zymeworks position peaked at $5.68M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.